JNJ

SEC source: 0001225208-24-001900 · doc4.xml · derivative · entry 5

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,739 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F1 · derivative.exercise_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

F1 · derivative.expiration_date: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001225208-24-001900 · doc4.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,416.001

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

SEC source: 0001225208-24-001900 · doc4.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,329.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.

SEC source: 0001225208-23-010867 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,489.8531

Underlying: Common Stock · 227.9731 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-008842 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,200.509

Underlying: Common Stock · 228.519 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-008458 · doc4.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,275.204

F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.

F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0001225208-23-008459 · doc4.xml · nonDerivative · entry 1

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,037.9545

F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.

F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0001225208-23-008460 · doc4.xml · nonDerivative · entry 1

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,051

F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.

F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0001225208-23-008461 · doc4.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,358

F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.

F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0001225208-23-008462 · doc4.xml · nonDerivative · entry 1

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,464.0055

F1 · kind: The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.

F2 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0000200406-26-000006 · wk-form5_1769642965.xml · nonDerivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89

F1 · price: On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

SEC source: 0001225208-23-007707 · doc4.xml · derivative · entry 3

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,698 shares

Expires 2024-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-007707 · doc4.xml · nonDerivative · entry 2

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,747

SEC source: 0001225208-23-007707 · doc4.xml · nonDerivative · entry 1

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-007708 · doc4.xml · nonDerivative · entry 1

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,696.0055

F1 · price: This transaction was executed in multiple trades at prices ranging from 170.16 to 170.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-23-006820 · doc4.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,933.8735

SEC source: 0001225208-23-006636 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,912.632

Underlying: Common Stock · 230.13 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-006233 · doc4.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,342.204

SEC source: 0001225208-23-005258 · doc4.xml · derivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Pharmaceuticals R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,765

Underlying: Common Stock · 75,765 shares

Expires not disclosed

F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F2 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F2 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-005247 · doc4.xml · derivative · entry 1

Adamczyk Darius · CIK 0001605056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,258.515

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005248 · doc4.xml · derivative · entry 1

DAVIS D SCOTT · CIK 0001227733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,799.498

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005249 · doc4.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,896.542

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005250 · doc4.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,498.858

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005251 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,624.9

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005252 · doc4.xml · derivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,429.5

Underlying: Common Stock · 1,429.5 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

SEC source: 0001225208-23-005253 · doc4.xml · derivative · entry 1

Joly Hubert · CIK 0001467638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,928.973

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005254 · doc4.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,996.899

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005255 · doc4.xml · derivative · entry 1

MULCAHY ANNE M · CIK 0001201725 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,493.757

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005256 · doc4.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,515.734

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-005257 · doc4.xml · derivative · entry 1

West Nadja · CIK 0001787802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,598.846

Underlying: Common Stock · 1,193.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-003666 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,430.925

Underlying: Common Stock · 233.63 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-003667 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,569.4483

Underlying: Common Stock · 201.405 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0001225208-23-003576 · doc4.xml · nonDerivative · entry 1

Swanson James D. · CIK 0001904785 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,215.3198

SEC source: 0001225208-23-002056 · doc4.xml · derivative · entry 4

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,224

Underlying: Common Stock · 1,224 shares

Expires not disclosed

F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F4 · derivative.exercise_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002056 · doc4.xml · derivative · entry 3

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,263

Underlying: Common Stock · 20,263 shares

Expires 2033-02-13

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002056 · doc4.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,203

SEC source: 0001225208-23-002056 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,643

F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.

SEC source: 0001225208-23-002057 · doc4.xml · derivative · entry 4

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,953

Underlying: Common Stock · 1,953 shares

Expires not disclosed

F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002057 · doc4.xml · derivative · entry 3

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,317

Underlying: Common Stock · 32,317 shares

Expires 2033-02-13

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002057 · doc4.xml · nonDerivative · entry 2

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,484

SEC source: 0001225208-23-002057 · doc4.xml · nonDerivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,408

F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.

SEC source: 0001225208-23-002058 · doc4.xml · derivative · entry 6

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 937

Underlying: Common Stock · 937 shares

Expires not disclosed

F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F6 · derivative.exercise_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

F6 · derivative.expiration_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002058 · doc4.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,756

Underlying: Common Stock · 7,756 shares

Expires 2033-02-13

F4 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002058 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,917

SEC source: 0001225208-23-002058 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,314

F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.

SEC source: 0001225208-23-002059 · doc4.xml · derivative · entry 5

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,409

Underlying: Common Stock · 10,409 shares

Expires not disclosed

F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F5 · derivative.exercise_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: The Restricted Share Units vest in three annual equal installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002059 · doc4.xml · derivative · entry 4

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,250

Underlying: Common Stock · 172,250 shares

Expires 2033-02-13

F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-23-002059 · doc4.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,393

SEC source: 0001225208-23-002059 · doc4.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,992

F1 · shares: Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.

SEC source: 0001225208-23-002060 · doc4.xml · derivative · entry 4

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,773

Underlying: Common Stock · 2,773 shares

Expires not disclosed

F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F4 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.